BioForce Nanosciences Holdings, Inc.
BFNH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9,996 | $58,836 | $58,251 | $35,126 |
| - Cash | $1 | $1 | $1 | $11 |
| + Debt | $0 | $221 | $174 | $116 |
| Enterprise Value | $9,995 | $59,056 | $58,424 | $35,231 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$490 | $0 | -$486 | -$502 |
| % Margin | – | – | – | – |
| Net Income | -$490 | -$472 | -$486 | -$502 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.017 | -0.016 | -0.017 | -0.017 |
| % Growth | -4.3% | 3% | 2.9% | – |
| Operating Cash Flow | -$61 | -$47 | -$68 | -$78 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$61 | -$47 | -$68 | -$78 |